Moderator in Pharma Session 1 – “In(gene)ious” but not patentable? Patentable subject matter
Monday, September 19, 2016 from 09.00 to 10.30
Penny has been a partner at Powell Gilbert since its formation in 2007. Prior to qualifying as a solicitor she obtained a degree in Biochemistry and a DPhil in molecular biology from the University of Oxford. Her strong scientific background in the life sciences has led to her specialisation in advising clients in the bio pharma sector. She represents clients before the UK patent courts, Court of Appeal and Supreme Court, including acting in the leading UK case on industrial application of gene sequences, HGS v Eli Lilly. She is often involved in the co-ordination of parallel European patent litigation strategy and in EPO opposition proceedings and has acted in referrals to the CJEU and EFTA court on SPC issues. She is a qualified mediator and a solicitor advocate.
Penny is currently President of the European Patent Lawyers Association (EPLAW). She is a member of the Editorial Boards of BioScience Law Review, and LSIPR and is a tutor on the Oxford University Diploma in Intellectual Property Law and Practice course, teaching patent litigation.